Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ticlopidine-induced elevated liver enzymes

T B Klepser1, G J Jogerst

  • 1College of Pharmacy, University of Iowa, Iowa City 52242, USA.

Pharmacotherapy
|July 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[ Depression during late period of life: perception of morbidity in elderly residents of St. Petersburg].

Advances in gerontology = Uspekhi gerontologii·2010
Same author

Medication discrepancies in an outpatient electronic medical record.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2001
Same author

Comparison of the serum and intracellular pharmacokinetics of azithromycin in healthy and diabetic volunteers.

Pharmacotherapy·2000
Same author

Community characteristics associated with elder abuse.

Journal of the American Geriatrics Society·2000
Same author

Assessment of patients' perceptions and beliefs regarding herbal therapies.

Pharmacotherapy·2000
Same author

Unsafe and potentially safe herbal therapies.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1999
Same journal

Comment on "Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis".

Pharmacotherapy·2026
Same journal

Response to Comment on "Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis".

Pharmacotherapy·2026
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
See all related articles

Ticlopidine offers an alternative for preventing stroke and myocardial infarction when aspirin fails. However, severe side effects like neutropenia and elevated liver function tests necessitate careful patient monitoring.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hepatology

Background:

  • Ticlopidine serves as an alternative antiplatelet therapy for patients intolerant or unresponsive to aspirin, aiming to prevent thrombotic events like stroke and myocardial infarction.
  • Despite its efficacy, ticlopidine is associated with a significant adverse effect profile that requires clinical vigilance.

Observation:

  • A specific case highlights the potential for ticlopidine to cause elevated liver function tests.
  • This observation underscores the importance of monitoring hepatic function in patients undergoing ticlopidine treatment.

Findings:

  • Ticlopidine, while a viable option for stroke and myocardial infarction prevention, carries risks including severe neutropenia.
  • Elevated liver function tests represent another potential adverse event associated with ticlopidine therapy.

Related Experiment Videos

Implications:

  • Clinicians must weigh the benefits of ticlopidine against its potential severe adverse effects, including hematologic and hepatic complications.
  • Close monitoring for adverse events, such as neutropenia and liver enzyme abnormalities, is crucial for patient safety when using ticlopidine.